Table 2.
ED-ALTO medication and opioid utilization pre-and post-implementation.
| Total Sample | 12 Months Pre-Implementation |
12 Months Post-Implementation |
p-Value | |
|---|---|---|---|---|
| N = 157,457 | N = 78,962 | N = 78,495 | ||
| ED-ALTO Medication Utilization | 53,639 (34.1) | 26,568 (33.6) | 27,071 (34.5) | <0.01 |
| Received any opioid, N (%) | 26,947 (17.4) | 13,968 (17.7) | 12,979 (16.5) | <0.01 |
| Morphine | 13,305 (8.4) | 6656 (8.4) | 6649 (8.5) | 0.77 |
| Dilaudid | 3436 (2.2) | 2140 (2.7) | 1296 (1.6) | <0.01 |
| Fentanyl | 6836 (4.4) | 3481 (4.4) | 3355 (4.3) | 0.19 |
| Hydrocodone | 4871 (3.1) | 2596 (3.3) | 2275 (2.9) | <0.01 |
| Oxycodone | 3660 (2.3) | 1802 (2.3) | 1858 (2.4) | 0.26 |
| Tramadol | 550 (0.3) | 284 (0.4) | 266 (0.3) | 0.48 |
| MME of Opioids a, mean (SD) | 20.8 (21.9) | 20.3 (20.3) | 21.3 (23.5) | <0.01 |
a Among patients who were prescribed opioids.